The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities
Over the years, researchers in drug discovery have taken advantage of the use of privileged structures to design innovative hit/lead molecules. The α-ketoamide motif is found in many natural products, and it has been widely exploited by medicinal chemists to develop compounds tailored to a vast rang...
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 2021-04, Vol.64 (7), p.3508-3545 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3545 |
---|---|
container_issue | 7 |
container_start_page | 3508 |
container_title | Journal of medicinal chemistry |
container_volume | 64 |
creator | Robello, Marco Barresi, Elisabetta Baglini, Emma Salerno, Silvia Taliani, Sabrina Settimo, Federico Da |
description | Over the years, researchers in drug discovery have taken advantage of the use of privileged structures to design innovative hit/lead molecules. The α-ketoamide motif is found in many natural products, and it has been widely exploited by medicinal chemists to develop compounds tailored to a vast range of biological targets, thus presenting clinical potential for a plethora of pathological conditions. The purpose of this perspective is to provide insights into the versatility of this chemical moiety as a privileged structure in drug discovery. After a brief analysis of its physical–chemical features and synthetic procedures to obtain it, α-ketoamide-based classes of compounds are reported according to the application of this motif as either a nonreactive or reactive moiety. The goal is to highlight those aspects that may be useful to understanding the perspectives of employing the α-ketoamide moiety in the rational design of compounds able to interact with a specific target. |
doi_str_mv | 10.1021/acs.jmedchem.0c01808 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8154582</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2505361317</sourcerecordid><originalsourceid>FETCH-LOGICAL-a515t-7ac2884f7d7575363bcddb48b6f5565f252b8a1c6121535589de67d0f29491e23</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS0EotPCGyDkJZsM_okTDwuk0aiUilZlUdaWY98krhIn2E6left6mGkFG1aW7HPOPb4fQh8oWVPC6Gdt4vphBGt6GNfEECqJfIVWVDBSlJKUr9GKEMYKVjF-hs5jfCCEcMr4W3TGeV2VpBIrtNz3gLfD3Gv8A9KEt6OzgG8nB2mPdcQa_wzu0Q3Qgc3XybXYeXwL1hnn9YB3ebqLKey_4N0SAviEr310XZ-y11t8OULonO_w3TxPIS3eJQfxHXrT6iHC-9N5gX59u7zffS9u7q6ud9ubQgsqUlFrw6Qs29rWoha84o2xtillU7VCVKJlgjVSU1NRRgUXQm4sVLUlLduUGwqMX6Cvx9x5aQ6ryvWCHtQc3KjDXk3aqX9fvOtVNz0qSUUp5CHg0ykgTL8XiEnl3xoYBu1hWqJiguRelNM6S8uj1IQpxgDtyxhK1IGYysTUMzF1IpZtH_-u-GJ6RpQF5Cj4Y5-WkNce_5_5BNA0puU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2505361317</pqid></control><display><type>article</type><title>The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities</title><source>ACS Publications</source><creator>Robello, Marco ; Barresi, Elisabetta ; Baglini, Emma ; Salerno, Silvia ; Taliani, Sabrina ; Settimo, Federico Da</creator><creatorcontrib>Robello, Marco ; Barresi, Elisabetta ; Baglini, Emma ; Salerno, Silvia ; Taliani, Sabrina ; Settimo, Federico Da</creatorcontrib><description>Over the years, researchers in drug discovery have taken advantage of the use of privileged structures to design innovative hit/lead molecules. The α-ketoamide motif is found in many natural products, and it has been widely exploited by medicinal chemists to develop compounds tailored to a vast range of biological targets, thus presenting clinical potential for a plethora of pathological conditions. The purpose of this perspective is to provide insights into the versatility of this chemical moiety as a privileged structure in drug discovery. After a brief analysis of its physical–chemical features and synthetic procedures to obtain it, α-ketoamide-based classes of compounds are reported according to the application of this motif as either a nonreactive or reactive moiety. The goal is to highlight those aspects that may be useful to understanding the perspectives of employing the α-ketoamide moiety in the rational design of compounds able to interact with a specific target.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.0c01808</identifier><identifier>PMID: 33764065</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><ispartof>Journal of medicinal chemistry, 2021-04, Vol.64 (7), p.3508-3545</ispartof><rights>2021 The Authors. Published by American Chemical Society</rights><rights>2021 The Authors. Published by American Chemical Society 2021 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a515t-7ac2884f7d7575363bcddb48b6f5565f252b8a1c6121535589de67d0f29491e23</citedby><cites>FETCH-LOGICAL-a515t-7ac2884f7d7575363bcddb48b6f5565f252b8a1c6121535589de67d0f29491e23</cites><orcidid>0000-0002-9814-7195 ; 0000-0002-7897-7917 ; 0000-0002-5835-7796 ; 0000-0001-8675-939X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c01808$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01808$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,314,776,780,881,2751,27055,27903,27904,56716,56766</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33764065$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Robello, Marco</creatorcontrib><creatorcontrib>Barresi, Elisabetta</creatorcontrib><creatorcontrib>Baglini, Emma</creatorcontrib><creatorcontrib>Salerno, Silvia</creatorcontrib><creatorcontrib>Taliani, Sabrina</creatorcontrib><creatorcontrib>Settimo, Federico Da</creatorcontrib><title>The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Over the years, researchers in drug discovery have taken advantage of the use of privileged structures to design innovative hit/lead molecules. The α-ketoamide motif is found in many natural products, and it has been widely exploited by medicinal chemists to develop compounds tailored to a vast range of biological targets, thus presenting clinical potential for a plethora of pathological conditions. The purpose of this perspective is to provide insights into the versatility of this chemical moiety as a privileged structure in drug discovery. After a brief analysis of its physical–chemical features and synthetic procedures to obtain it, α-ketoamide-based classes of compounds are reported according to the application of this motif as either a nonreactive or reactive moiety. The goal is to highlight those aspects that may be useful to understanding the perspectives of employing the α-ketoamide moiety in the rational design of compounds able to interact with a specific target.</description><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAUhS0EotPCGyDkJZsM_okTDwuk0aiUilZlUdaWY98krhIn2E6left6mGkFG1aW7HPOPb4fQh8oWVPC6Gdt4vphBGt6GNfEECqJfIVWVDBSlJKUr9GKEMYKVjF-hs5jfCCEcMr4W3TGeV2VpBIrtNz3gLfD3Gv8A9KEt6OzgG8nB2mPdcQa_wzu0Q3Qgc3XybXYeXwL1hnn9YB3ebqLKey_4N0SAviEr310XZ-y11t8OULonO_w3TxPIS3eJQfxHXrT6iHC-9N5gX59u7zffS9u7q6ud9ubQgsqUlFrw6Qs29rWoha84o2xtillU7VCVKJlgjVSU1NRRgUXQm4sVLUlLduUGwqMX6Cvx9x5aQ6ryvWCHtQc3KjDXk3aqX9fvOtVNz0qSUUp5CHg0ykgTL8XiEnl3xoYBu1hWqJiguRelNM6S8uj1IQpxgDtyxhK1IGYysTUMzF1IpZtH_-u-GJ6RpQF5Cj4Y5-WkNce_5_5BNA0puU</recordid><startdate>20210408</startdate><enddate>20210408</enddate><creator>Robello, Marco</creator><creator>Barresi, Elisabetta</creator><creator>Baglini, Emma</creator><creator>Salerno, Silvia</creator><creator>Taliani, Sabrina</creator><creator>Settimo, Federico Da</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9814-7195</orcidid><orcidid>https://orcid.org/0000-0002-7897-7917</orcidid><orcidid>https://orcid.org/0000-0002-5835-7796</orcidid><orcidid>https://orcid.org/0000-0001-8675-939X</orcidid></search><sort><creationdate>20210408</creationdate><title>The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities</title><author>Robello, Marco ; Barresi, Elisabetta ; Baglini, Emma ; Salerno, Silvia ; Taliani, Sabrina ; Settimo, Federico Da</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a515t-7ac2884f7d7575363bcddb48b6f5565f252b8a1c6121535589de67d0f29491e23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Robello, Marco</creatorcontrib><creatorcontrib>Barresi, Elisabetta</creatorcontrib><creatorcontrib>Baglini, Emma</creatorcontrib><creatorcontrib>Salerno, Silvia</creatorcontrib><creatorcontrib>Taliani, Sabrina</creatorcontrib><creatorcontrib>Settimo, Federico Da</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Robello, Marco</au><au>Barresi, Elisabetta</au><au>Baglini, Emma</au><au>Salerno, Silvia</au><au>Taliani, Sabrina</au><au>Settimo, Federico Da</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2021-04-08</date><risdate>2021</risdate><volume>64</volume><issue>7</issue><spage>3508</spage><epage>3545</epage><pages>3508-3545</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>Over the years, researchers in drug discovery have taken advantage of the use of privileged structures to design innovative hit/lead molecules. The α-ketoamide motif is found in many natural products, and it has been widely exploited by medicinal chemists to develop compounds tailored to a vast range of biological targets, thus presenting clinical potential for a plethora of pathological conditions. The purpose of this perspective is to provide insights into the versatility of this chemical moiety as a privileged structure in drug discovery. After a brief analysis of its physical–chemical features and synthetic procedures to obtain it, α-ketoamide-based classes of compounds are reported according to the application of this motif as either a nonreactive or reactive moiety. The goal is to highlight those aspects that may be useful to understanding the perspectives of employing the α-ketoamide moiety in the rational design of compounds able to interact with a specific target.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>33764065</pmid><doi>10.1021/acs.jmedchem.0c01808</doi><tpages>38</tpages><orcidid>https://orcid.org/0000-0002-9814-7195</orcidid><orcidid>https://orcid.org/0000-0002-7897-7917</orcidid><orcidid>https://orcid.org/0000-0002-5835-7796</orcidid><orcidid>https://orcid.org/0000-0001-8675-939X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 2021-04, Vol.64 (7), p.3508-3545 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8154582 |
source | ACS Publications |
title | The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T20%3A52%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Alpha%20Keto%20Amide%20Moiety%20as%20a%20Privileged%20Motif%20in%20Medicinal%20Chemistry:%20Current%20Insights%20and%20Emerging%20Opportunities&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Robello,%20Marco&rft.date=2021-04-08&rft.volume=64&rft.issue=7&rft.spage=3508&rft.epage=3545&rft.pages=3508-3545&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.0c01808&rft_dat=%3Cproquest_pubme%3E2505361317%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2505361317&rft_id=info:pmid/33764065&rfr_iscdi=true |